- Report
- April 2025
- 175 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1374EUR$1,500USD£1,168GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1145EUR$1,250USD£973GBP
- Report
- July 2022
- 65 Pages
Global
From €3206EUR$3,500USD£2,725GBP
Growth Hormone Secretagogues (GHSs) are a class of drugs used to treat endocrine and metabolic disorders. They are used to stimulate the release of growth hormone from the pituitary gland, which helps to regulate metabolism, body composition, and other physiological processes. GHSs are used to treat growth hormone deficiency, as well as other conditions such as Prader-Willi Syndrome, Turner Syndrome, and idiopathic short stature. GHSs are also used off-label to treat obesity, muscle wasting, and other conditions.
GHSs are available in both oral and injectable forms, and are typically prescribed in combination with other medications. Common side effects of GHSs include headache, nausea, and dizziness.
Some companies in the Growth Hormone Secretagogue market include Novo Nordisk, Pfizer, Eli Lilly, and Ipsen. Show Less Read more